BR112018067784A2 - regime de dosagem para o tratamento de exacerbações agudas de condições inflamatórias - Google Patents
regime de dosagem para o tratamento de exacerbações agudas de condições inflamatóriasInfo
- Publication number
- BR112018067784A2 BR112018067784A2 BR112018067784A BR112018067784A BR112018067784A2 BR 112018067784 A2 BR112018067784 A2 BR 112018067784A2 BR 112018067784 A BR112018067784 A BR 112018067784A BR 112018067784 A BR112018067784 A BR 112018067784A BR 112018067784 A2 BR112018067784 A2 BR 112018067784A2
- Authority
- BR
- Brazil
- Prior art keywords
- treatment
- dosage regimen
- inflammatory conditions
- acute exacerbations
- exacerbations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
a presente invenção refere-se a um novo regime de dosagem para administração de 3-[5-amino-4-(3-cianobenzoil)-pirazol-1-il]-n-ciclopropil-4-metilbenzamida ou um derivado farmaceuticamente aceitável da mesma, a saber, no tratamento de exacerbações agudas de condições inflamatórias.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/GB2016/050635 WO2017153701A1 (en) | 2016-03-08 | 2016-03-08 | Dosage regimen for the treatment of acute exacerbations of inflammatory conditions |
Publications (1)
Publication Number | Publication Date |
---|---|
BR112018067784A2 true BR112018067784A2 (pt) | 2019-01-15 |
Family
ID=55646778
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BR112018067784A BR112018067784A2 (pt) | 2016-03-08 | 2016-03-08 | regime de dosagem para o tratamento de exacerbações agudas de condições inflamatórias |
Country Status (9)
Country | Link |
---|---|
US (1) | US10617674B2 (pt) |
JP (1) | JP6741773B2 (pt) |
KR (1) | KR20180119597A (pt) |
AU (1) | AU2016397046B2 (pt) |
BR (1) | BR112018067784A2 (pt) |
CA (1) | CA3016368A1 (pt) |
MX (1) | MX2018010781A (pt) |
RU (1) | RU2709509C1 (pt) |
WO (1) | WO2017153701A1 (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6741774B2 (ja) * | 2016-03-08 | 2020-08-19 | メレオ バイオファーマ 1 リミテッド | 慢性閉塞性肺疾患の急性増悪の治療のための投与レジメン |
GB201612240D0 (en) | 2016-07-14 | 2016-08-31 | Mereo Biopharma 1 Ltd | Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide |
GB201612238D0 (en) | 2016-07-14 | 2016-08-31 | Mereo Biopharma 1 Ltd | Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-Yl]-n-cyclopropyl-4-methylbenzamide |
PT3585382T (pt) * | 2017-12-11 | 2021-08-19 | Mereo Biopharma 1 Ltd | Utilização de 3-[5-amino-4-(3-cianobenzoil)-pirazol-1-il]-n-ciclopropil-4-metilbenzamida no tratamento de exacerbações agudas da doença pulmonar obstrutiva crónica |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9501841D0 (en) | 1995-01-31 | 1995-03-22 | Co Ordinated Drug Dev | Improvements in and relating to carrier particles for use in dry powder inhalers |
US6598603B1 (en) | 1997-12-31 | 2003-07-29 | Astra Aktiebolag | Method for treating respiratory diseases |
JP4838121B2 (ja) * | 2003-06-26 | 2011-12-14 | ノバルティス アーゲー | 5員ヘテロ環を基礎とするp38キナーゼ阻害剤 |
RU2381219C2 (ru) * | 2003-06-26 | 2010-02-10 | Новартис Аг | ПРОИЗВОДНЫЕ 5-ЧЛЕННЫХ ГЕТЕРОЦИКЛОВ В КАЧЕСТВЕ ИНГИБИТОРОВ КИНАЗЫ p38 |
TW201705980A (zh) * | 2004-04-09 | 2017-02-16 | 艾伯維生物技術有限責任公司 | 用於治療TNFα相關失調症之多重可變劑量療法 |
GB0409703D0 (en) | 2004-04-30 | 2004-06-02 | Vectura Ltd | Pharmaceutical compositions |
US20050277602A1 (en) * | 2004-05-21 | 2005-12-15 | Grunstein Michael M | Methods employing agonists of P38 map kinase for the treatment of asthma |
US20090270350A1 (en) * | 2006-02-10 | 2009-10-29 | Pfizer Inc. | Pyridinone Pyrazole Urea and Pyrimidinone Pyrazole Urea Derivatives |
GB0603684D0 (en) | 2006-02-23 | 2006-04-05 | Novartis Ag | Organic compounds |
HUE032004T2 (en) * | 2012-03-20 | 2017-08-28 | Mereo Biopharma 1 Ltd | Use of a pyrazole derivative for the treatment of acute severe conditions of chronic obstructive airways disease |
-
2016
- 2016-03-08 AU AU2016397046A patent/AU2016397046B2/en active Active
- 2016-03-08 MX MX2018010781A patent/MX2018010781A/es unknown
- 2016-03-08 JP JP2018547430A patent/JP6741773B2/ja active Active
- 2016-03-08 KR KR1020187026085A patent/KR20180119597A/ko not_active Application Discontinuation
- 2016-03-08 CA CA3016368A patent/CA3016368A1/en not_active Abandoned
- 2016-03-08 RU RU2018132046A patent/RU2709509C1/ru active
- 2016-03-08 US US16/082,772 patent/US10617674B2/en active Active
- 2016-03-08 WO PCT/GB2016/050635 patent/WO2017153701A1/en active Application Filing
- 2016-03-08 BR BR112018067784A patent/BR112018067784A2/pt not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
JP2019507785A (ja) | 2019-03-22 |
WO2017153701A1 (en) | 2017-09-14 |
MX2018010781A (es) | 2018-11-09 |
CA3016368A1 (en) | 2017-09-14 |
AU2016397046A1 (en) | 2018-09-06 |
US10617674B2 (en) | 2020-04-14 |
JP6741773B2 (ja) | 2020-08-19 |
RU2709509C1 (ru) | 2019-12-18 |
KR20180119597A (ko) | 2018-11-02 |
AU2016397046B2 (en) | 2022-05-12 |
US20190091203A1 (en) | 2019-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP18093777A (es) | Derivados de pirazolopirimidina como inhibidor de quinasa | |
CY1122046T1 (el) | Δικυκλικα ετεροκυκλικα παραγωγα ως αναστολεις βρομοτομεων | |
MX2022007989A (es) | Composiciones y metodos para tratar pterigion. | |
SV2018005687A (es) | Derivados de dihidroimidazopirazinona usados en el tratamiento del cancer | |
CY1122469T1 (el) | Υπογλωσσια φαρμακοτεχνικη μορφη ριλουζολης | |
UY35972A (es) | Inhibidores macrocíclicos de fxia que tienen grupos heterocíclicos | |
EA201691600A1 (ru) | Дигидропиридиноновые ингибиторы mgat2 для применения в лечении метаболических нарушений | |
SV2016005313A (es) | Derivados de carboxamida | |
BR112018067784A2 (pt) | regime de dosagem para o tratamento de exacerbações agudas de condições inflamatórias | |
BR112018067454A2 (pt) | regime de dosagem para o tratamento de exacerbações agudas de doença pulmonar obstrutiva crônica | |
DK4058148T3 (da) | Doseringsregime for anti-bcma-midler | |
CY1122979T1 (el) | Φαρμακευτικη συνθεση για τη θεραπεια της μυκητιασης | |
ECSP19000169A (es) | Formulaciones inyectables fisiológicamente balanceadas de fosnetupitant | |
BR112017004552A2 (pt) | composições farmacêuticas | |
PH12016502547A1 (en) | Methods for treating infections | |
AR109209A1 (es) | Composición farmacéutica para prevención o tratamiento de enfermedades neurodegenerativas | |
CL2017000026A1 (es) | Formas de dosificación farmacéutica | |
EA201792265A1 (ru) | Способы лечения сердечно-сосудистых заболеваний | |
BR112017017774A2 (pt) | composto, composição farmacêutica e método para fabricar um medicamento | |
CR20160591A (es) | Metodos para tratar infecciones | |
MX2015003939A (es) | Combinacion y composicion farmaceutica que contiene un antimicrobiano y un antimicotico. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B07D | Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette] |
Free format text: DE ACORDO COM O ARTIGO 229-C DA LEI NO 10196/2001, QUE MODIFICOU A LEI NO 9279/96, A CONCESSAO DA PATENTE ESTA CONDICIONADA A ANUENCIA PREVIA DA ANVISA. CONSIDERANDO A APROVACAO DOS TERMOS DO PARECER NO 337/PGF/EA/2010, BEM COMO A PORTARIA INTERMINISTERIAL NO 1065 DE 24/05/2012, ENCAMINHA-SE O PRESENTE PEDIDO PARA AS PROVIDENCIAS CABIVEIS. |
|
B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
B06U | Preliminary requirement: requests with searches performed by other patent offices: procedure suspended [chapter 6.21 patent gazette] | ||
B350 | Update of information on the portal [chapter 15.35 patent gazette] | ||
B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
B09B | Patent application refused [chapter 9.2 patent gazette] |